Leverage the power of real-world data to validate commercial launch strategies, plan for label expansions, support regulatory compliance, and enhance market access.
COTA data can help you build a strong case for coverage and provide leverage in pricing negotiations with payers, while also enabling you to better understand market uptake of your drug.
Extend the product lifecycle with label expansion submissions supported by real-world patient data.
Equip your sales team with real-world evidence studies to address provider inquiries that extend beyond existing clinical trial data, focusing on the drug’s impact on specific populations within the real-world treatment setting.
*Depending on diagnosis
Vantage is perfect for R&D teams looking to get a high-level view of a specific cancer diagnosis. Vantage provides regulatory-grade patient data that is curated for your specific use case. This data can be used for identifying trends in treatment response, uncovering outlying subpopulations, and testing hypotheses to inform future drug research.
Vista offers comprehensive insights into the pathways of oncology patients throughout the disease spectrum, integrating non-oncological information to reveal epidemiological trends and inform research strategies.
Real-World Insights and Support is an optional, complementary add-on service that adds personalized expertise and support to your data. Our clinical and statistical experts work either as clinical advisors or as the execution arm of your team (depending on the data you choose) to provide statistical analysis and streamline study designs.
Contact COTA to learn more about solutions for cancer commercial teams.
